Lixia Luo

机构：Duke Medical Center · ORCID：0000-0002-8413-0501

发表论文 154 篇 · 总被引 1331 次 · h-index 17

代表论文

• Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma (2025 · Clinical Cancer Research · 被引 6)
• Loss of function of Atrx recapitulates phenotypes of alternative lengthening of telomeres in a primary mouse model of sarcoma (2025 · iScience · 被引 3)
• Lgr5+ Stem Cells Maintain Apex Position in Cell Hierarchy of the Intestinal Epithelium During Homeostasis and Injury (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma (2026 · JCI Insight)
• Retraction of: The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma (2025 · Aging)
• Oncogenic Ppm1d mutations deregulate the p53 pathway in primary mouse gliomas (2025 · bioRxiv (Cold Spring Harbor Laboratory))